Antifungal agent susceptibilities and interpretation of Malassezia pachydermatis and Candida parapsilosis isolated from dogs with and without seborrheic dermatitis skin

References

• Gupta AK, Batra R, Bluhm R, Boekhout T, Dawson TL. Skin diseases associated with Malassezia species. J Am Acad Dermatol 2004;51: 785–798.
   PubMed Web of Science ®Google Scholar
• Uchida Y, Mizutani M, Kubo T, Nakade T, Otomo K. Otitis externa induced with Malassezia pachydermatis in dogs and the efficacy of pimaricin. J Vet Med Sci 1992;54: 611–614.
   Google Scholar
• Kennis RA, Rosser EJ, Olivier NB, Walker RW. Quantity and distribution of Malassezia organisms on the skin of clinically normal dogs. J Am Vet Med Assoc 1996;208: 1048–1051.
   PubMed Web of Science ®Google Scholar
• Brito EH, Fontenelle RO, Brilhante RS, et al. The anatomical distribution and antimicrobial susceptibility of yeast species isolated from healthy dogs. Vet J 2009;182: 320–326.
   PubMedGoogle Scholar
• Yurayart C, Chindamporn A, Suradhat S, et al. Comparative analysis of the frequency, distribution and population sizes of yeasts associated with canine seborrheic dermatitis and healthy skin. Vet Microbiol 2011;148: 356–362.
   Google Scholar
• Carlotti DN. How to treat atopic dermatitis in dogs. Eur J Companion Animal Practice 2009;19: 268–275.
   Google Scholar
• Peano A, Gallo MG. Management of Malassezia-related diseases in the dog. Parassitologia 2008;50: 85–88.
   Google Scholar
• Akerstedt J, Vollset I. Malassezia pachydermatis with special reference to canine skin disease. Br Vet J 1996;152: 269–281.
   Google Scholar
• Chang HJ, Miller HL, Watkins N, et al. An epidemic of Malassezia pachydermatis in an intensive care nursery associated with colonization of health care workers’ pet dogs. N Engl J Med 1998;338: 706–711.
   PubMed Web of Science ®Google Scholar
• Morris DO. Malassezia pachydermatis carriage in dog owners. Emerg Infect Dis 2005;11: 83–88.
   PubMed Web of Science ®Google Scholar
• Robson D. Malassezia: Mechanisms of possible drug resistance. Australia College of Veterinary Scientists Dermatology Chapter Science Week Proceedings, Gold Coast; 6–7 July 2007: 63–67.
   Google Scholar
• Chen TA, Hill PB. The biology of Malassezia organisms and their ability to induce immune responses and skin disease. Vet Dermatol 2005;16: 4–26.
   PubMed Web of Science ®Google Scholar
• Mirhendi H, Makimura K, Zomorodian K, et al. A simple PCR-RFLP method for identification and differentiation of 11 Malassezia species. J Microbiol Methods 2005;61: 281–284.
   PubMedGoogle Scholar
• Kaneko T, Makimura K, Abe M, et al. Revised culture-based system for identification of Malassezia species. J Clin Microbiol 2007;45: 3737–3742.
   PubMedGoogle Scholar
• Oliveira Gdos S, Ribeiro ET, Baroni Fde A. An evaluation of manual and mechanical methods to identify Candida spp. from human and animal sources. Rev Inst Med Trop Sao Paulo 2006;48: 311–315.
   Google Scholar
• Gupta AK, Kohli Y, Summerbell RC. Molecular differentiation of seven Malassezia species. J Clin Microbiol 2000;38: 1869–1875.
   Web of Science ®Google Scholar
• Clinical Laboratory Standards Institute. Method for antifungal disk diffusion susceptibility testing in yeasts. Approved guideline, M44-A. Wayne, PA: CLSI; 2002.
   Google Scholar
• Testore GP, Dori L, Buonomini AR, et al. In vitro fluconazole susceptibility of 1565 clinical isolates of Candida species evaluated by the disk diffusion method performed using NCCLS M44-A guidelines. Diagn Microbiol Infect Dis 2004;50: 187–192.
   PubMed Web of Science ®Google Scholar
• Carrillo-Munoz AJ, Abarca L, Quindos G, et al. Multicenter evaluation of Neo-Sensitabs, a standardized diffusion method for yeast susceptibility testing. Rev Iberoam Micol 1999;16: 92–96.
   Google Scholar
• Clinical Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast: Approved Guideline M27-A3. Wayne, PA: CLSI; 2007.
   Google Scholar
• Garau M, Pereiro M Jr, del Palacio A. In vitro susceptibilities of Malassezia species to a new triazole, albaconazole (UR-9825), and other antifungal compounds. Antimicrob Agents Chemother 2003;47: 2342–2344.
   PubMed Web of Science ®Google Scholar
• Velegraki A, Alexopoulos EC, Kritikou S, Gaitanis G. Use of fatty acid RPMI 1640 media for testing susceptibilities of eight Malassezia species to the new triazole posaconazole and to six established antifungal agents by a modified NCCLS M27-A2 microdilution method and Etest. J Clin Microbiol 2004;42: 3589–3593.
   PubMedGoogle Scholar
• Kiraz N, Dag I, Oz Y, et al. Correlation between broth microdilution and disk diffusion methods for antifungal susceptibility testing of caspofungin, voriconazole, amphotericin B, itraconazole and fluconazole against Candida glabrata. J Microbiol Methods 2010;82: 136–140.
   Google Scholar
• Prado MR, Brito EH, Brilhante RS, et al. Subculture on potato dextrose agar as a complement to the broth microdilution assay for Malassezia pachydermatis. J Microbiol Methods 2008;75: 341–343.
   Google Scholar
• Brito EH, Fontenelle RO, Brilhante RS, et al. Phenotypic characterization and in vitro antifungal sensitivity of Candida spp. and Malassezia pachydermatis strains from dogs. Vet J 2007;174: 147–153.
   Google Scholar
• Vandenbossche I, Vaneechoutte M, Vandevenne M, De Baere T, Verschraegen G. Susceptibility testing of fluconazole by the NCCLS broth macrodilution method, E-test, and disk diffusion for application in the routine laboratory. J Clin Microbiol 2002;40: 918–921.
   PubMed Web of Science ®Google Scholar
• Hazen KC, Baron EJ, Colombo AL, et al. Comparison of the susceptibilities of Candida spp. to fluconazole and voriconazole in a 4-year global evaluation using disk diffusion. J Clin Microbiol 2003;41: 5623–5632.
   PubMedGoogle Scholar
• Pfaller MA, Messer SA, Boyken L, et al. Evaluation of the NCCLS M44-P disk diffusion method for determining susceptibilities of 276 clinical isolates of Cryptococcus neoformans to fluconazole. J Clin Microbiol 2004;42: 380–383.
   Google Scholar
• Matar MJ, Ostrosky-Zeichner L, Paetznick VL, et al. Correlation between E-test, disk diffusion, and microdilution methods for antifungal susceptibility testing of fluconazole and voriconazole. Antimicrob Agents Chemother 2003;47: 1647–1651.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Kohli Y, Li A, Faergemann J, Summerbell RC. In vitro susceptibility of the seven Malassezia species to ketoconazole, voriconazole, itraconazole and terbinafine. Br J Dermatol 2000;142: 758–765.
   PubMed Web of Science ®Google Scholar
• Rincon S, Cepero de Garcia MC, Espinel-Ingroff A. A modified Christensen's urea and CLSI broth microdilution method for testing susceptibilities of six Malassezia species to voriconazole, itraconazole, and ketoconazole. J Clin Microbiol 2006;44: 3429–3431.
   PubMed Web of Science ®Google Scholar
• Nijima M, Kano R, Nagata M, Hasegawa A, Kamata H. An azole-resistant isolate of Malassezia pachydermatis. Vet Microbiol 2011;149: 288–290.
   PubMed Web of Science ®Google Scholar
• Cafarchia C, Figueredo LA, Iatta R, Montagna MT, Otranto D. In vitro antifungal susceptibility of Malassezia pachydermatis from dogs with and without skin lesions. Vet Microbiol 2012;155: 395–398.
   PubMed Web of Science ®Google Scholar
• Jesus FP, Lautert C, Zanette RA, et al. In vitro susceptibility of fluconazole-susceptible and -resistant isolates of Malassezia pachydermatis against azoles. Vet Microbiol 2011;152: 161–164.
   PubMed Web of Science ®Google Scholar
• Peano A, Beccati M, Chiavassa E, Pasquetti M. Evaluation of the antifungal susceptibility of Malassezia pachydermatis to clotrimazole, miconazole and thiabendazole using a modified CLSI M27-A3 microdilution method. Vet Dermatol 2012;23: 131–135, e129.
   Google Scholar
• Hensel P, Austel M, Wooley RE, Keys D, Ritchie BW. In vitro and in vivo evaluation of a potentiated miconazole aural solution in chronic Malassezia otitis externa in dogs. Vet Dermatol 2009;20: 429–434.
   Google Scholar
• Cafarchia C, Figueredo LA, Iatta R, et al. In vitro evaluation of Malassezia pachydermatis susceptibility to azole compounds using E-test and CLSI microdilution methods. Med Mycol 2012;50: 795–801.
   PubMed Web of Science ®Google Scholar
• Sims CR, Paetznick VL, Rodriguez JR, Chen E, Ostrosky-Zeichner L. Correlation between microdilution, E-test, and disk diffusion methods for antifungal susceptibility testing of posaconazole against Candida spp. J Clin Microbiol 2006;44: 2105–2108.
   PubMed Web of Science ®Google Scholar
• Alexander BD, Byrne TC, Smith KL, et al. Comparative evaluation of Etest and sensititre yeastone panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents. J Clin Microbiol 2007;45: 698–706.
   PubMed Web of Science ®Google Scholar
• Sanglard D. Clinical relevance of mechanisms of antifungal drug resistance in yeasts. Enferm Infecc Microbiol Clin 2002;20: 462–469; quiz 470, 479.
   PubMedGoogle Scholar
• Johnson MD, Perfect JR. Use of antifungal combination therapy: agents, order, and timing. Curr Fungal Infect Rep 2010;4: 87–95.
   PubMedGoogle Scholar
• Zomorodian K, Rahimi MJ, Pakshir K, et al. Determination of antifungal susceptibility patterns among the clinical isolates of Candida species. J Glob Infect Dis 2011;3: 357–360.
   Google Scholar
• Miceli MH, Díaz JA, Lee SA. Emerging opportunistic yeast infections. The Lancet Infectious Diseases 2011;11: 142–151.
   PubMed Web of Science ®Google Scholar
• Anderson JB. Evolution of antifungal-drug resistance: mechanisms and pathogen fitness. Nat Rev Microbiol 2005;3: 547–556.
   PubMed Web of Science ®Google Scholar
• Nakano Y, Wada M, Tani H, Sasai K, Baba E. Effects of beta-thujaplicin on anti-Malassezia pachydermatis remedy for canine otitis externa. J Vet Med Sci 2005;67: 1243–1247.
   Google Scholar